Share this article

 Email

 Print

 

Republish this article

The text of this article by Futurity is licensed under a Creative Commons Attribution-No Derivatives License.

More
Health & Medicine

Lower obesity rates for kids in traditional families

Daily calcium linked to longer life in women

Drug blunts cocaine addiction in mice

Where visual search happens in the brain

Childhood CT scans slightly raise cancer risk

Polio virus engineered to kill brain tumor

Cartilage gets bum rap for osteoarthritis

How to decide if a daily aspirin is harmful

Anxiety drug reduces MS symptoms in mice

Doctors have called upon their fellow physicians to limit or end the practice of prescribing memory-enhancing drugs to healthy children whose brains are still developing.

The position statement issued by doctors at Yale University’s School of Medicine and the American Academy of Neurology (AAN) is published in the journal Neurology.

The statement was written to address the growing trend in which teens use “study drugs” before tests and parents request attention deficit hyperactivity disorder (ADHD) drugs for children who don’t meet the criteria for the disorder. The AAN spent several years analyzing all of the available research and ethical issues to develop this official position statement on the topic.

“Doctors caring for children and teens have a professional obligation to always protect the best interests of the child, to protect vulnerable populations, and to prevent the misuse of medication,” says first author of the statement, William Graf, professor of pediatrics and neurology at Yale School of Medicine.

“The practice of prescribing these drugs, called neuroenhancements, for healthy students is not justifiable.”

Graf and a group of child neurologists provide evidence that points to dozens of ethical, legal, social, and developmental reasons why prescribing mind-enhancing drugs, such as those used to treat ADHD, for healthy people is viewed differently in children and adolescents than it would be in functional, independent adults with full decision-making capacities.

Some of the reasons not to prescribe neuroenhancements include:

• the child’s best interest,
• the long-term health and safety of neuroenhancements, which has not been studied in children,
• kids and teens may lack complete decision-making capacities while their judgments and cognitive abilities are still developing,
• maintaining doctor-patient trust,
• the risks of over-medication and dependency.

“A physician should talk to the child about the request, as it may reflect other medical, social, or psychological motivations such as anxiety, depression, or insomnia,” says Graf, who notes that there are alternatives to neuroenhancements available, including maintaining good sleep, nutrition, study habits, and exercise regimens.

Source: Yale University